Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-02T19:58:05.514Z Has data issue: false hasContentIssue false
  • English
  • Français

Newer Antipsychotics and the Differences Between Clinical Experiences and Clinical Trials

Published online by Cambridge University Press:  07 November 2014

Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
In Session
Information
CNS Spectrums , Volume 12 , Issue 11 , November 2007 , pp. 812 - 815
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Lieberman, JA, Stroup, TS, McEvoy, JP, et al.Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209–1223.CrossRefGoogle ScholarPubMed
2.Jeste, DV, Okamoto, A, Napolitano, J, Kane, JM, Martinez, RA. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone. Am J Psychiatry. 2000;157:1150–1155.CrossRefGoogle ScholarPubMed
3.Jeste, DV. Tardive dyskinesia rates with atypical antipsychotics in older adults. J Clin Psychiatry. 2004;65(suppl 9):21–24.Google ScholarPubMed
4.Reist, C, Mintz, J, Albers, LJ, Jamal, MM, Szabo, S, Ozdemir, V. Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002. J Clin Psychopharmacol. 2007;27:46–51.CrossRefGoogle ScholarPubMed